Readystate Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.78M	Buy	+11,601	New	+$3.78M	0.12%	114
2024 Q3	–	Sell	-9,600	Closed	-$2.33M	–	291
2024 Q2	$2.33M	Buy	+9,600	New	+$2.33M	0.08%	118